Nordson Corp
nordson.comWhat Do They Do?
Makes precision equipment for applying and controlling fluids, testing products and treating surfaces, along with medical components for industrial, electronics and medical manufacturers.
10-K for FY2025, filed Dec 17, 2025Nordson is an innovative precision technology company that leverages a scalable growth framework to deliver top tier growth with leading…View ↗
We are a diversified precision technology company that engineers, manufactures, and markets differentiated products and systems used to…View ↗
This segment delivers proprietary dispensing and material processing technology to diverse end markets. Product line specific solutions…View ↗
This segment includes components and device solutions for medical, life science, high-tech industrial, and other diverse end markets.View ↗
This segment integrates our proprietary product technologies into the progressive stages of a customer’s production processes, such as…View ↗
How Do They Make Money?
Manufacturers generally pay for products when Nordson ships them; customers with certain custom products pay as the work progresses.
10-K for FY2025, filed Dec 17, 2025Revenue recognition — A contract exists when it has approval and commitment from both parties, the rights of the parties are identified…View ↗
For certain contracts related to the sale of customer-specific products, revenue is recognized over time as we satisfy performance…View ↗
As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance…View ↗
-
10-K for FY2025, filed Dec 17, 2025
FY2025 revenue by reportable segment ↗
$2.8B
-
10-K for FY2025, filed Dec 17, 2025
$2.8B ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Industrial Precisions Solutions
Sold outright
10-K for FY2025, filed Dec 17, 2025 |
48%
FY2022: 52%
|
Industrial Precisions Solutions, FY2025
$1.3B Sources
|
Sold outright |
|
Medical Fluid Systems
Sold outright
10-K for FY2025, filed Dec 17, 2025 |
30%
FY2022: 27%
|
Medical Fluid Systems, FY2025
$835.4M Sources
|
Sold outright |
|
Advanced Technology Systems
Sold outright
10-K for FY2025, filed Dec 17, 2025 |
22%
FY2022: 22%
|
Advanced Technology Systems, FY2025
$624.5M Sources
|
Sold outright |
Who Are Their Customers?
Manufacturers in consumer and industrial markets, plus medical and electronics producers, buy Nordson’s systems and components mainly through a direct sales force, with qualified distributors and sales representatives also selling them.
10-K for FY2025, filed Dec 17, 2025Nordson is an innovative precision technology company that leverages a scalable growth framework to deliver top tier growth with leading…View ↗
We market our products globally, primarily through a direct sales force and qualified distributors and sales representatives. We have built…View ↗
This segment delivers proprietary dispensing and material processing technology to diverse end markets. Product line specific solutions…View ↗
This segment includes components and device solutions for medical, life science, high-tech industrial, and other diverse end markets.View ↗
This segment integrates our proprietary product technologies into the progressive stages of a customer’s production processes, such as…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 17 cents of every revenue dollar as net income in FY2025 and turned 24 cents into free cash flow.
10-K for FY2025, filed Dec 17, 2025
$711.7MView ↗
10-K for FY2025, filed Dec 17, 2025
$484.5MView ↗
10-K for FY2025, filed Dec 17, 2025
$661.1MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q3 FY2026, filed Aug 20, 2026
$152.8MView ↗
- ▲ +22%
- vs $125.8M in Q3 FY2025
10-Q for Q3 FY2026, filed Aug 20, 2026
Open tableView ↗
-
Aug 19, 2026
Raised full-year sales and adjusted earnings guidance
Sales outlook is $3,035 to $3,075 million, with adjusted earnings of $11.80 to $12.00 per diluted share.
Sources
8-K, filed Aug 19, 2026
Based on the continuing momentum of our end markets as evidenced by our backlog and order entry, the Company is increasing its full year…View ↗
-
May 20, 2026
Raised full-year sales and adjusted earnings guidance
Sales outlook is $2,930 to $3,010 million, with adjusted earnings of $11.30 to $11.80 per diluted share.
Sources
8-K, filed May 20, 2026
Based on the continuing momentum of our end markets as evidenced by our backlog and order entry, the Company is increasing its full year…View ↗
-
Feb 18, 2026
Raised full-year sales and adjusted earnings guidance
Sales outlook is $2,860 to $2,980 million, with adjusted earnings of $11.00 to $11.60 per diluted share.
Sources
8-K, filed Feb 18, 2026
Based on the strong start to the year, the second quarter outlook and the current foreign exchange rate environment, the Company is…View ↗
Growing. Revenue grew 18% in 4 years, from $2.4B in FY2021 to $2.8B in FY2025, about 4% a year.
Loading...
